BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10989687)

  • 41. Human immunodeficiency virus type II (HIV-2) testing: a perspective.
    Glassman AB
    Ann Clin Lab Sci; 1992; 22(5):283-5. PubMed ID: 1524400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups].
    Soriano V; Hewlett I; Tor J; Esteve M; Granada I; Muga R; Epstein J; Medrano L
    Med Clin (Barc); 1991 Oct; 97(12):441-5. PubMed ID: 1753812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-1: absence of infection in subjects with indeterminate western blot.
    Migali E; Mariotti D; Lovari A; Tenani T; Imperiali P; Ozzola G
    Allergol Immunopathol (Madr); 1993; 21(2):61-5. PubMed ID: 8337990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].
    Sanz del Forcallo FJ; García Delgado R; Ortiz Maslloréns F
    Rev Clin Esp; 1989 Dec; 185(9):443-7. PubMed ID: 2696006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-course detection of HIV-1 proviral DNA and genomic RNA by polymerase chain reaction in sera from seropositive and seronegative hemophiliacs treated with clotting factor concentrates.
    Morita T; Kawabata H; Yanagihara Y; Horikoshi Y; Mimaya J
    Int J Hematol; 1993 Oct; 58(3):225-32. PubMed ID: 8148500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevalence of HIV1 and HIV2 infection in women living in an area of Lisboa City].
    Teles Lda C; Guerreiro D; Lourenço MH; Ferreira MO; Victorino RM
    Acta Med Port; 1991; 4(2):64-70. PubMed ID: 1867118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Isolation of human immunodeficiency virus (HIV) in epidemic area of HIV infection in Yunnan Province].
    Shao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Jun; 12(3):129-35. PubMed ID: 1713810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular epidemiology of HIV type 2 infections in South India.
    Gurjar RS; Ravi V; Desai A
    AIDS Res Hum Retroviruses; 2009 Mar; 25(3):363-72. PubMed ID: 19327056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
    Brennan CA; Lund JK; Golden A; Yamaguchi J; Vallari AS; Phillips JF; Kataaha PK; Jackson JB; Devare SG
    AIDS; 1997 Dec; 11(15):1823-32. PubMed ID: 9412700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 proviral DNA sequences of env gp41 PCR amplificates from Tanzania.
    Holm-Hansen C; Ayehunie S; Johansson B; Nkya W; Shao J; Haukenes G
    APMIS; 1996 Jun; 104(6):459-64. PubMed ID: 8774676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.
    Sayre KR; Dodd RY; Tegtmeier G; Layug L; Alexander SS; Busch MP
    Transfusion; 1996 Jan; 36(1):45-52. PubMed ID: 8607152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic characterization of HIV type 1 and type 2 from Bissau, Guinea-Bissau (West Africa).
    Esteves A; Parreira R; Piedade J; Venenno T; Canas-Ferreira WF
    Virus Res; 2000 Jun; 68(1):51-61. PubMed ID: 10930662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of the reactivity of HIV 1 positive sera with synthetic peptides for understanding antigenic differences between circulating strains.
    Cernescu C; Ruţă SM
    Rev Roum Virol; 1993; 44(3-4):175-86. PubMed ID: 7826868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological, virological, and polymerase chain reaction studies of HIV type 1 and HIV type 2 infections in Ghanaian patients with AIDS and AIDS-related complex.
    Ayisi NK; Mensah M; Ishikawa K; Sata T
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):319-21. PubMed ID: 7742046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction of HIV type 1 subtype E virus into South Korea.
    Lee JS; Nam JG; Kim EY; Kang C; Koo BK; Cho HW
    AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1083-7. PubMed ID: 10933624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences.
    Esteves A; Piedade J; Santos C; Venenno T; Canas-Ferreira WF; Parreira R
    AIDS Res Hum Retroviruses; 2001 Feb; 17(3):253-6. PubMed ID: 11177408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status.
    De Socio GV; Falcinelli C; Francisci D; Pauluzzi S; Cosmi EV; Anceschi MM
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):403-7. PubMed ID: 1670043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The detection of HIV-1 proviral DNA by PCR in clotted blood specimens.
    Boriskin YuS ; Booth JC; Fernando S; Carrington D; Evans MR; Hay P; Coates AR
    J Virol Methods; 1995 Mar; 52(1-2):87-94. PubMed ID: 7769042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary HIV-1 antibody patterns by western blot assay.
    Tiensiwakul P
    Clin Lab Sci; 1998; 11(6):336-8. PubMed ID: 10345498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live-cell immunofluorescence for detection of human immunodeficiency virus type 1 (HIV-1)-related antigens in peripheral blood mononuclear cells from HIV-1 seropositive individuals.
    Valensin PE; Zazzi M; Valassina M; Bianchi Bandinelli ML; Toti M; Almi P; Rubino M; Caruso A
    Microbiologica; 1989 Oct; 12(4):281-9. PubMed ID: 2685514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.